Vor Ort
Merkzettel Warenkorb
  • Produktbild: Ethical Issues in International Biomedical Research
  • Produktbild: Ethical Issues in International Biomedical Research

Ethical Issues in International Biomedical Research A Casebook

106,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

12.01.2011

Herausgeber

Lavery James V. + weitere

Verlag

Oxford University Press

Seitenzahl

400

Maße (L/B/H)

24/16,1/2,6 cm

Gewicht

686 g

Sprache

Englisch

ISBN

978-0-19-517922-4

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

12.01.2011

Herausgeber

Verlag

Oxford University Press

Seitenzahl

400

Maße (L/B/H)

24/16,1/2,6 cm

Gewicht

686 g

Sprache

Englisch

ISBN

978-0-19-517922-4

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Ethical Issues in International Biomedical Research
  • Produktbild: Ethical Issues in International Biomedical Research

    • FOREWORD

    • INTRODUCTION

    • SECTION I: COLLABORATIVE PARTNERSHIP

    • Case 1. Community involvement in biodiversity prospecting in Mexico

    • Case 2. Selling genes: consulting a genetic population database in Tonga

    • Case 3: Substantiality of a fluoride varnish feasability study in Nicaragua

    • SECTION II: SCIENTIFIC VALIDITY

    • Case 4: Malarone testing in pregnant women in Thailand

    • Case 5: Neglected diseases: Incentives to Conduct Research in Developing Countries: the case of Pharamomycin for visceral leishmaniasis in India

    • SECTION III: SCIENTIFIC VALIDITY

    • Case 7. The limitations of knowledge: equipsoise and a randomized treatment strategy for malaria in Ethiopia

    • Case 8. Controversy surrounding the scientific value of the Vaxgen/Aventis (RV-144) Phase III

    • SECTION IV: FAIR SUBJECT AND COMMUNITY SELECTION

    • Case 9. Pharmaceutical research in developing countries: testing a new sufracant in Bolivia

    • Case 10: Trading Genes for Toothbrushes: Research with the Aka Pygmy people in the Central African Republic

    • Case 11: Test Phase I malaria vaccine: where should the research be conducted?

    • SECTION V: FAVOURABLE RISK/BENEFIT ASSESSMENT

    • Case 12: Ethical complcations during an investigation of malaria infection in native Amazonian populations in western Brazil

    • Case 13: Access to treatment for trial participants who become infected with HIV during the course of Phase I trials of a preventive HIV vaccine in South Africa

    • SECTION VI: INDEPENDENT REVIEW

    • Case 14: How independent is independent review? Partner notification in a study of sexually-transmitted diseases in Mpumalanga, South Africa

    • Case 15: Which regulations protect subjects best: preventing HIV status disclosure in a community-based circumcision study in rural Uganda

    • SECTION VII: INFORMED CONSENT

    • Case 16: The challenge of informed consent in a genetic epidemiology study of noma in rural Nigeria

    • Case 17: Compensation to families who consent to research autopsy for their children in a study of malaria mortality in Malawi: respectful or coercive?

    • SECTION VIII: RESPECT FOR ENROLLED SUBJECTS AND THEIR COMMUNITIES

    • Case 18: A randomized trial of low-phytate corn for maternal-infant micronutrient deficiency in Guatemala

    • Case 19: Obligations to participants harmed in the course of the N-9 multi-centre vaginal microbicide trial in South Africa

    • Case 20: Ethical challenges and controversy in a retrospective study of HIV-1 transmission in Uganda

    • Case 21: Protecting subjects in a study of domestic violence in South Africa: what services are researchers obligated to provide?

    • APPENDIX I: ECONOMIC, SOCIAL, HEALTH AND DEVELOPMENT INDICATORS FOR THE CASE COUNTRIES